Bevacizumab

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26902 publications

Development of a Freeze-Dried Bevacizumab Kit for 99mTc Radiolabeling and Preclinical Evaluation In Vitro and in Normal Mice.

Development of a Freeze-Dried Bevacizumab Kit for 99mTc Radiolabeling and Preclinical Evaluation In Vitro and in Normal Mice.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: June 24, 2026

Personalized Dosing System Guided by Cross-Scale Metabolic Imaging Biomarkers in Neovascular Age-Related Macular Degeneration.

Personalized Dosing System Guided by Cross-Scale Metabolic Imaging Biomarkers in Neovascular Age-Related Macular Degeneration.

Journal: Translational vision science & technology

Published: June 23, 2026

Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.

Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.

Journal: Journal of vitreoretinal diseases

Published: June 23, 2026

Streptococcus salivarius endophthalmitis and corneal ring infiltrate after intravitreal bevacizumab injection.

Streptococcus salivarius endophthalmitis and corneal ring infiltrate after intravitreal bevacizumab injection.

Journal: GMS ophthalmology cases

Published: June 19, 2026

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Trends in the Initial Treatment for Retinopathy of Prematurity in the United States.

Journal: Ophthalmic surgery, lasers & imaging retina

Published: June 18, 2026

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

Journal: Technology in cancer research & treatment

Published: June 17, 2026

Correction: Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study.

Correction: Safety and efficacy of nab-paclitaxel combined with nedaplatin and bevacizumab in patients with platinum-resistant epithelial ovarian cancer: a retrospective cohort study.

Journal: Journal of cancer research and clinical oncology

Published: June 16, 2026

Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients.

Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients.

Journal: Cancer immunology, immunotherapy : CII

Published: June 10, 2026

Postoperative Outcomes in Combined Phacovitrectomy vs Vitrectomy Alone in Severe Diabetic Retinopathy.

Postoperative Outcomes in Combined Phacovitrectomy vs Vitrectomy Alone in Severe Diabetic Retinopathy.

Journal: Journal of vitreoretinal diseases

Published: June 08, 2026

Underfunding of a Patient Copay Assistance Program and the Impact on Retinal Disease Care: Survey of ASRS Members.

Underfunding of a Patient Copay Assistance Program and the Impact on Retinal Disease Care: Survey of ASRS Members.

Journal: Journal of vitreoretinal diseases

Published: June 08, 2026

Structural and thermal stability assessment of repackaged bevacizumab using RT-PCR-based differential scanning fluorimetry and intrinsic fluorescence spectroscopy.

Structural and thermal stability assessment of repackaged bevacizumab using RT-PCR-based differential scanning fluorimetry and intrinsic fluorescence spectroscopy.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 02, 2026

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol.

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol.

Journal: BMJ open

Published: June 02, 2026

Showing 1-12 of 26,902

Last Updated: 06/30/2026